Intense Circuit Resistance Training along with Zataria multiflora Supplementation Reduced Plasma Retinol Binding Protein-4 and Tumor Necrosis Factor-α in Postmenopausal Females

authors:

avatar Seyed Morteza Tayebi 1 , * , avatar Peiman Hasannezhad 2 , avatar Ayoub Saeidi 3 , avatar Mohammad Reza Fadaei 2

Core Research of Health Physiology and Physical Activity, Department of Exercise Physiology, Faculty of Sport Science, Allameh Tabataba’i University, Tehran, IR Iran
Department of Physical Education and Sport Science, Rasht branch, Islamic Azad University, Rasht, IR Iran
Exercise Biochemistry Division, Faculty of Sport Science, University of Mazandaran, Babolsar, IR Iran

how to cite: Tayebi S M, Hasannezhad P, Saeidi A, Fadaei M R. Intense Circuit Resistance Training along with Zataria multiflora Supplementation Reduced Plasma Retinol Binding Protein-4 and Tumor Necrosis Factor-α in Postmenopausal Females. Jundishapur J Nat Pharm Prod. 2018;13(2):e38578. https://doi.org/10.17795/jjnpp.38578.

Abstract

Background:

It is observed that the levels of retinol binding protein-4 (RBP-4) and cytokine tumor necrosis factor-α (TNF-α) in people with obesity, diabetes and low physical activity, such as postmenopausal females, are more than those of the healthy individuals.

Objectives:

The current study aimed to investigate the effect of eight weeks of circuit resistance training (CRT) and Zataria multiflora supplementation (ZMSuppl) on RBP-4 and TNF-α in postmenopausal females.

Methods:

Forty-eight untrained postmenopausal females participated in the study and were divided into four groups (n = 12) of control (Con), CRT, ZMSuppl and CRT along with ZMSuppl (CRT + ZMSuppl). CRT program included 12 stations (30 seconds for each station, 85% one repetition maximum) for eight weeks (three sessions/week). 500 mg of ZMSuppl was consumed daily after breakfast in ZMSuppl and CRT + ZMSuppl groups. Blood samples were taken 48 hours before the first session and 48 hour after the last session of training to measure plasma RBP-4 and TNF-α.

Results:

A significant reduction was observed in plasma TNF-α in the CRT + ZMSuppl group in comparison with Con (P < 0.05). In addition, a significant reduction was observed in plasma RBP-4 in both CRT and CRT + ZMSuppl groups in comparison with Con (P < 0.01) and ZMSuppl (P < 0.01).

Conclusions:

The current study showed that intense CRT causes significant reduction only in plasma RBP-4; but this reduction was higher in RBP-4 and also in TNF-α, when ZMSuppl was added to CRT. Therefore, it may be an effective method to reduce disorders and abnormalities related to inflammatory factors resulting from menopause.

1. Background

Adipokines, substances that are directly produced by fat cells, affect inflammatory responses cause insulin resistance and increase the risk of cardiovascular diseases (1).

A large number of studies confirmed that the relationship between circulation levels of retinol binding protein-4 (RBP-4), an adipokine, is derived from adipocyte, various aspects of obesity (2), insulin resistance and sensitivity (3), type 2 diabetes (4) and metabolic syndrome (5). It seems appropriate to reduce insulin sensitivity to resistance and risk factors of cardiovascular diseases in different patients (6).

Tumor necrosis factor-α (TNF-α), another adipokine related to obesity and insulin resistance (7, 8), is a multi-functional cytokine that can regulate many cellular and biological processes, such as immune function, cell differentiation, proliferation, apoptosis and cell metabolism. Many studies reported increased serum TNF-α in obesity, while weight loss is associated with its reduction (9).

On the other hand, menopause is a phenomenon associated with aging in females (10). The development of abdominal obesity and as a result increased incidence of metabolic syndrome and type 2 diabetes in females after menopause are mainly associated with loss of the protective role of estrogen and a relative increase in androgen circulation (11). Also, in menopause, decreased circulation of sex hormones causes pro-inflammatory activities (12). In addition, menopause increases obesity that plays a role in systemic inflammation (12).

Nowadays, the importance of exercise in reducing inflammation and inflammatory factors is considered more (13). Exercise increases the blood flow, capillary density, muscle mass, glycogen storage capacity due to increased glycogen synthase, increase in muscle glucose transport protein (GLUT4), improving and increasing glucose uptake rate by muscles, improving insulin sensitivity and efficiency, reducing insulin resistance, increasing gene expression or activities of different proteins involved in insulin signaling cascade, and reduces weight and RBP-4 concentration in untrained people and those with impaired glucose tolerance and diabetes (14-16).

But recently, resistance training (RT) or weight training is a common means to improve health and increase muscle mass (16). RT is a treatment program by American heart association (AHA) (17) and American college of sports medicine (ACSM) (18). A study showed that muscle hypertrophy due to RT was associated with lower levels of inflammatory markers and cytokines (19). In addition, RT with high intensity may compensate for reduction in bone mass and muscle strength regarding age in postmenopausal females (20). Traditional RT causes increase in strength, fat free mass, bone density, and also improvement in blood lipid, but has no significant effect on cardio-respiratory endurance. But, RT in circuit style (circuit resistance training/CRT) causes improvement in cardio-respiratory endurance and can be a kind of exercise to improve both strength and cardio-respiratory endurance (21).

On the other hand, the proper combination of diet and exercise can have a positive effect on health-related quality of life than any of them alone (22). New researchers tended to use herbal medicines with regard to complications caused by chemical medicines. Zataria sp. is a plant belonging to Labiatae family with the scientific name Zataria multiflora (ZM) that grows only in Iran, Pakistan and Afghanistan (23). ZM, due to its excellent properties, is widely used as tea, spices, and herbal medicine is widely used to treat asthma and is used as an antiseptic of stomach and urinary tract as well as diuretic and anti-inflammatory in traditional medicine (24). ZM contains phenolic compounds such as carvacrol, thymol, and gamma-terpinene with anti-inflammatory effects (23, 25). Research shows that compounds containing ZM can inhibit the reactions of inflammatory mediators and act as an antioxidant, antispasmodic, and anti-pain (25). In a study, ZM was effective in the treatment of primary dysmenorrhea (26). Recently, in animal models, thymol and carvacrol acted as bioactive compounds reducing pre-inflammatory cytokine levels of interleukin (IL)-1β, IL-6, and TNF-α and increasing anti-inflammatory cytokines (27, 28). Also, a recent study showed that ZM can increase adipokine level, which may be due to increased gamma peroxisome proliferator-activated receptor (PPAR) protein (23). These effects may contribute to control the symptoms of menopause via anti-inflammatory effects and probably the balance of lipid tissue adipokine still is not investigated.

2. Objectives

Based on the symptoms of menopause, it is necessary to find new ways to decline or even control it; according to the literature about physiological and mechanical effect of CRT (in comparison with traditional RT) for menopausal females and anti-inflammatory effects of ZM, it seems that its parallel effect is helpful for females who developed menopause. Therefore, the current study aimed to investigate the effect of eight weeks of CRT with ZM supplementation (ZMSuppl) on RBP-4 and TNF-α in postmenopausal females.

3. Methods

The study was semi-experimental with pretest and post-test design. The study was approved by the research ethics committee of the Iranian sport sciences research institute, and conducted in accordance with the Declaration of Iranian ministry of health.

Subjects Eighty eight postmenopausal females volunteered through public call in public centers and offices in Tehran. Postmenopausal status of females was specified based on age range from literatures and also an interview by a gynecologist. Before participating in the study, all procedures were explained to the volunteers and after complete awareness of the study terms and the completion of a medical questionnaire, a written informed consent was obtained from them. Inclusion criteria were passing at least six months from menopause development, lack of addiction to drugs and alcohol, lack of regular exercise history for at least six months, no history of renal, hepatitis, cardiovascular disease, diabetes and/or any physical injury or problem as a physical activity obstacle. After examination by a gynecologist, the subjects enrolled into the study. Among them, 48 subjects with the age range of 48 - 65 years were randomly selected after approval by a cardiologist. Then, based on weight, height, and body mass index (BMI), subjects were matched and divided into four groups (n = 12): control, ZMSuppl, CRT, and CRT combined with ZMSuppl (CRT + ZMSuppl) (Table 1).

Table 1.

Demographic Characteristic of Participantsa

GroupsControlZMSupplCRTCRT + ZMSuppl
Age, y56.5 ± 4.254.4 ± 3.958.03 ± 4.753.8 ± 6.0
Height, cm156.7 ± 3.0160.9 ± 4.0158.7 ± 3.8159.2 ± 4.6
Weight, kg68.7 ± 13.366.4 ± 10.967.8 ± 13.0170.1 ± 10.8
BMI, Kg/m228.27 ± 4.225.93 ± 2.527.22 ± 1.827.81 ± 2.0

3.1. Preparation of ZM Essence

ZM leaves were collected in March around the gardens of Eghlid city, Iran. Then, they were dried in the shade for 10 days. ZM leaves were dried in an oven for 48 hours at 32°C and then powder in a Chinese pounder. A 50 g of the sample powder was boiled for 3 hours using water distillation method in Clevenger and at boiling point. The essential oil was filtered, then dried on anhydrous sodium sulfate, and finally transferred into a capped glass container and stored at 4°C. The yield was calculated as dry essential volume divided by the initial dry powder weight multiplied by 100. The calculated yield was 3% (29).

3.2. Combination Assessment of ZM Essence by Gas Chromatography-Mass Spectrometry (GC-MS)

To isolate and identify components of ZM essence, GC-MS was used. GC-MS analysis was conducted by Agilent 5975 mass spectrometer detector (MSD) coupled with gas chromatography model of Agilent USA GC 7890A MS 5975C. The used column was of welded silica HP-5 (5% phenyl, 1.95% polydimethyl siloxane) with the profile of 30 × 0.25 mm2 id and film thickness of 0.25 μm. Helium was used as the carrying gas, and flow rate of gradient was 1 mL/minute. The thermal program was as follows: First, the column temperature was set at 50°C for five minutes, then it was increased 3°C per minute to 240°C, then it was increased 5°C per minute to 300°C, and finally set for three minutes at this temperature. The stored essential oil samples were diluted by n-hexane at a ratio of 1:10 and 1 µL was injected in the gas chromatography. The temperature at the injector and detector was fixed at 290°C. Compounds in ZM essence were identified using fragmentation pattern in the database of wiley7n.l and NIST08 and also using retention time in chromatography column (29). For each combination, the ratio of the level below peak was the total levels below peak of all compounds and the results are summarized in the Table 2.

Table 2.

Compounds of Zataria multiflora

CompoundInhibition Time, minUnder Peak Level, %
Thymol35.9026.8
Carvacrol36.5022.9
P-cymene21.737.7
γ-Terpinene23.556.8
α-Pinene16.533.2
β-Caryophyllene41.363
Carvacrol methyl ether32.862.4
α-Terpinene21.122.2
Spathulenol47.962
Linalool25.591.8
β-Myrcene19.601.5
Total-80.3

3.3. How to Use

A 500 mg of dried and powdered ZM leaves were filled in capsules via Chinese oven and prepared for use. Afterwards, groups of ZMSuppl and CRT + ZMSuppl received 500 mg of ZM every day after breakfast, one capsule (500 mg) with 100 mL of water. Groups of CRT (85%) and Control also consumed 100 mL of water with placebo capsules (Empty Capsules) after breakfast.

Training protocol CRT protocol was in such a way that before CRT, first the subjects were familiarized with the environment and exercises for a week and then one repetition maximum (1RM) of given exercises was determined. Sessions were conducted using circuit exercises’ design principles as an upper-body exercise and lower-body exercises as well as multi-joint movements at the beginning of the movements. Exercises included: 1. Squat, 2. Chest press, 3. Leg press, 4. Standing military press, 5. Knee extension, 6. Seated cable rowing, 7. Knee curl, 8. Biceps curl, 9. standing calf raise, 10. Triceps press, 11. Back extension, and 12. Crunch; 1RM was calculated using Brzycki equation (Equation 1).

Equation 1.

Subjects in CRT and CRT + ZMSuppl groups did the exercises with 85% of 1RM, at medium speed for eight weeks (three sessions per week). Each training session included five minutes warm-up and then doing 12 non-stop exercises between stations and duration of each station was 30 seconds. The number of repetitions at each station was recorded for the subjects. In each session, two sets (turn) of 12 exercises were carried out; between each turn, there was a three minutes active rest (30). Nutritional characteristics were recorded by subjects in the following two steps. All the subjects had a diet for two weeks. Subjects were advised to eat the same and specified food two days before blood sampling of pre-test and post-test (24 hours before the start of exercise or the first blood sampling, or pre-test and 24 hours after the end of exercise, the second blood sampling, or pre-test). The amount of nutrients received by subjects was calculated in all groups using the method described by McCance (31) (Table 3).

Table 3.

Analysis of Received Nutrienta

GroupsControlZMSupplCRTCRT + ZMSuppl
Pre TrainingPost TrainingPre TrainingPost TrainingPre TrainingPost TrainingPre TrainingPost Training
Total calorie, kcal/d2225 ± 1902396 ± 1032203 ± 1572317 ± 982142 ± 1252276 ± 1802096 ± 1132162 ± 125
Total protein, g/d111 ± 16112 ± 17112 ± 14110 ± 18110.5 ± 17108 ± 19104 ± 16102 ± 19
Protein, g/kgBW/d1.05 ± 0.451.2 ± 0.41.1 ± 0.41.0 ± 0.31.0 ± 0.31.1 ± 0.11.1 ± 0.21.1 ± 0.2
Total protein, % energy3.18 ± 4.119.6 ± 3.518.4 ± 4.219.7 ± 4.919.5 ± 4.619.0 ± 4.220.9 ± 4.819.3 ± 3.8
Total Carbohydrate, g/d295 ± 19304 ± 23285 ± 20289 ± 25248 ± 18250 ± 24252 ± 17245 ± 22
Total carbohydrate, % energy48.5 ± 6.950.8 ± 7.147.4 ± 7.250.5 ± 7.045.5 ± 9.849.0 ± 7.245.7 ± 10.149.3 ± 7.3
Total fat g/d81.5 ± 2177.3 ± 2783.5 ± 2378.0 ± 2677.0 ± 2271.0 ± 2570.0 ± 1766.0 ± 19
Total fat, % energy31.9 ± 7.628.8 ± 6.932.5 ± 6.929.0 ± 6.432.6 ± 7.031.4 ± 6.531.8 ± 9.230.1 ± 6.3

For blood sampling, the following requirements were needed: 1. Non use of drugs and/or supplement during the study, 2. No change in diet at least two days before the test, 3. Lack of exercise other than the exercises of the study and a long walk at least 72 hours before the test, 4. Not drinking coffee, dark tea, bananas, cereal and heavy or greasy foods at least 24 hours before the test.

In two steps of 48 hours before the start of training and 48 hours after the last training session blood samples were taken after 12 hours of overnight fasting from a vein in the arm in a sitting position and poured in test tubes containing ethylenediaminetetraacetic acid (EDTA) and tubes without anticoagulant; samples were centrifuged at 3000 rpm for 10 minutes and, plasma that was used for the analysis of RBP-4 and TNF-α was separated. RBP-4 and TNF-α of plasma were measured using kits of Abcam Co., with Cat. No. ab108897 and ab46087, with sensitivity of 6 ng/mL and 10 pg/mL by ELISA method, respectively.

3.4. Statistical Analysis

The Kolmogorov-Smirnov and Leven tests were used to determine normality of data and homogeneity of variances, respectively. To compare data of the four groups, analysis of covariance (ANCOVA) was used. Alpha was considered at the level of 0.05. All data were analyzed using software SPSS version 22.

4. Results

Kolmogorov-Smirnov test showed that data distribution was normal (P > 0.05) and also Leven test showed that variances were homogenous (P > 0.05).

ANCOVA revealed that plasma levels of RBP-4 changed significantly in adaptation to CRT and ZMSuppl (f = 19.217, P = 0.001). Therefore, based on pairwise comparisons, plasma RBP-4 did not significantly change with ZMSuppl (P = 1.000); but, decreased significantly after eight weeks of CRT (P = 0.001), CRT + ZMSuppl (P = 0.001); therefore, the differences of plasma RBP-4 changes between these groups with ZMSuppl were significant ((P = 0.001) and (P = 0.001), respectively) (Figure 1).

Changes of Plasma RBP-4 in Adaptation with Circuit Resistance Training
ZMSuppl, Zataria multiflora supplementation; CRT, circuit resistance training. *Significant difference with control at P < 0.01. #Significant difference with ZMSuppl group at P < 0.01. Covariates appearing in the model are evaluated at the following values: pretest = 133.8554.

ANCOVA revealed that plasma levels of TNF-α changed significantly in adaptation to CRT and ZMSuppl (f = 4.884, P = 0.005). Therefore, plasma TNF-α did not significantly change with ZMSuppl (P = 0.558) and CRT (P = 0.14); but, decreased significantly after eight weeks of CRT + ZMSuppl (P = 0.003); therefore, the differences of plasma TNF-α changes between this group with those of ZMSuppl and CRT were not significant ((P = 0.296) and (P = 0.988), respectively) (Figure 2).

Changes of Plasma TNF-a in Adaptation with Circuit Resistance Training
ZMSuppl, Zataria multiflora supplementation; CRT, circuit resistance training. *Significant difference with control at P < 0.01. Covariates appearing in the model are evaluated at the following values: pretest = 2.6012.

5. Discussion

The findings of the current study showed that both eight weeks of CRT with 85% of 1RM and CRT + ZMSuppl in postmenopausal females in comparison to the control and alone ZMSuppl groups caused significant decrement in plasma RBP-4. Increased plasma values of RBP-4 are introduced as one of the factors affecting glucose intolerance disorder and diabetes in human and animal samples. The results of research shows that exercise training in untrained people and those with impaired glucose tolerance and diabetes caused reduction in RBP-4 concentration and weight (16). Conflicting results are reported on changes in plasma levels of RBP-4 after doing different training programs. Suri et al. also showed that eight weeks of alternative aerobic training (70% - 85% of heart rate (HR)max) causes significant reduction in the serum RBP-4 in patients with type 2 diabetes; also, a significant relationship was observed between baseline levels and changes in RBP-4. In addition, low levels of RBP-4 and triglycerides were associated with improved insulin resistance and increased insulin sensitivity (32). Graham et al. showed that four weeks of aerobic endurance exercise resulted in a significant decrement in plasma RBP-4 and insulin sensitivity increase in subjects with diabetes (33). But Choi et al. showed that 12 weeks of combined aerobic and RT (60% -75% of HRmax and 50% - 70% of 1RM) did not lead to significant changes in plasma RBP-4 in females with obesity (34). It seems that changes in plasma RBP-4 (decrement or no change) in adaptation to training is closely related to changes in weight and fat percentage (32-34), BMI, waist to hip ratio (34), and lipid profile (32-34). In the current study, also, subjects’ levels of lipid profile, body composition and insulin sensitivity were measured; however, due to being used in other reports, the values were not reported and can be subject to changes. Changes observed in insulin sensitivity are introduced as the main factor affecting RBP-4 changes. Graham et al. in another study showed that RBP-4 values through doing exercises significantly reduced only in patients with high insulin resistance, that is, a significant relationship was observed between the values of RBP-4 and insulin resistance index [the homeostatic model assessment (HOMA)-IR] (33). In another study, no significant relationship was observed between RBP-4 and insulin resistance index (HOMA-IR). The researchers believed that RBP-4 was not a proper index to determine insulin resistance (35). However, in another study by Cho et al. (36), the importance of RBP-4 was noted as a marker of insulin resistance and factor affecting secreting pancreatic beta cells. The researchers considered lack of a significant relationship between RBP-4 values and insulin resistance index (HOMA-IR) in relation to the small sample size. In general, the role of exercise in increasing insulin function by reducing the accumulation of intracellular triglyceride, increased fatty acid oxidation and mitochondrial biogenesis is well established (37).

But, on the other hand, the results of the current study showed a significant reduction in plasma levels of TNF-α in postmenopausal females only in CRT + ZMSuppl group compared to the control group. In other words, TNF-α was not affected by ZMSuppl alone and/or CRT alone; but, the cumulative effect of ZMSuppl and CRT could affect it. TNF-α is a complex cytokine that results in inhibition of lipoprotein lipase and stimulates lipolysis in adipocytes and increases unsaturated fatty acids in blood flow in such a way that the outcome is increased insulin resistance and diabetes (38). It is expressed more in lipid tissue and muscles of people with obesity and may inhibit insulin act in other tissues (37). However, it remains unclear, despite low concentrations of TNF-α, whether serum TNF-α inhibits insulin act. It is thought that TNF-α produced through fatty tissue locally affect insulin act by autocrine or paracrine methods and then secrete into the serum. Thus, increased production of TNF-α in lipid tissue may be the result of increased levels of TNF-α in blood circulation (38). Exercise can directly reduce cytokines’ production in lipid tissue, muscle, and mononuclear cells and indirectly increase insulin sensitivity and improve endothelial function. It is shown that acute and short-term exercise may be associated with increased levels of inflammatory adipocytokines, but doing a variety of regular exercises reduce circulating levels of inflammatory markers, even in the thin people (39). Training causes protection against insulin resistance caused by TNF-α. It also leads to reduced levels of TNF-α and IL-6 and increased levels of anti-inflammatory substances, such as IL-4 and IL-10 (40). Reduced TNF-α as a result of training may also be applied by IL-6-dependent and non-dependent paths (41, 42). In addition, training increases the levels of epinephrine and finally inhibits and reduces TNF-α response (43). Weight loss caused by doing training leads to reduced volume and the number of adipocytes and reduces the number of macrophages and endothelial cells. Increased production of anti-inflammatory mediators by adipocytes and production of hepatic fibrinogen and other pre-inflammatory mediators are other results of weight loss caused by training. However, the mechanism of the effect of circuit resistance training on reducing inflammation is not known well. It seems that intensive resistance training results in a significant reduction in plasma levels of TNF-α, even if no tangible and significant changes are observed in body composition and body fat mass. Results of a study showed that doing a combination of aerobic and resistance training with high intensity for 12 months as compared to aerobic training reduced the values of TNF-α more (44). This variable is independently associated with changes in fasting insulin. This relationship may be associated with TNF-α act and/or the production in muscles, since changes in TNF-α is positively associated with changes in body mass with no fat. On the other hand, studies showed that the transition from pre-menopause to menopause increases abdominal fat independent of the effects of age and total body fat. Given that obesity (due to the production and expression of pro-inflammatory cytokine gene of TNF-α) is a factor associated with high inflammation levels (11, 45), therefore, reducing body fat and increasing lipolysis due to physical activity is a mechanism that reduces inflammation. An important feature of the current study was that the weight and body mass of subjects were the same as before the start of the study. This separates the effect of training from the effect of the weight and body mass. Also, it is shown, that the relationship between more physical activity and physical fitness and less inflammation is independent of obesity (17). Thus, according to the current study matched subjects, it seems that there are other mechanisms by which physical activities reduce inflammation.

In addition to the positive role of resistance training on the reduction of inflammatory factors, such as reducing the RBP-4 in CRT, when ZM intervention was added to the study (CRT + ZMSuppl), it reduced plasma RBP-4 and also TNF-α.

ZM has several compounds (such as thymol and carvacrol). The cumulative effects are attributed to these compounds that can prevent fat deposit in vessels (46). Also, ZM reduces the levels of blood triglycerides due to possessing terpenoids and flavonoids compounds. In addition, ZM has a very high antioxidant feature, which in addition to reducing blood fat can inhibit low density lipoprotein (LDL) (28). Therefore, considering the significant relationship between RBP-4 blood triglycerides, it seems that ZM can also reduceRBP-4 by reducing blood triglyceride. In the past two decades, ZM’s anti-inflammatory and oxidative anti-stress effects are reported (47). Lee and Shibamoto proved the antioxidant effects of ZM (48). Dorman et al. indicated that one of the best sources of natural antioxidants is phenolic compounds in the herbal essentials, especially ZM (49). Recent studies showed that phenolic compounds in ZM and its derivatives are responsible for its antioxidant activity, which lead to a significant reduction in serum LDL levels and markers of oxidative stress (50). Sabu et al. showed that polyphenols available in the plant inhibit lipid peroxidation, radicals’ superoxide, and reduces serum glucose levels in diabetic rats. Polyphenols available in green tea increase the antioxidant capacity (51). Rana and Soni found that ZM improves antioxidant potential and thus prevents oxidative stress (52). Joekim et al. reported that the effect of cyclooxygenase enzymes and oxidative stress on changes during development and cell differentiation such as a variety of cancers was proved and it was found out that in ZM, there are compounds that inhibit the mentioned enzymes and/or their antioxidant effects reduce oxidative stress (53). Also, Diaz-Cruz et al. found that cyclooxygenase through prostaglandin E2 production increases aromatase enzyme that can convert androgens to estrogen. On the other hand, compounds available in Zataria sp. by aromatase inhibition by cyclooxygenase inhibitors reduce estrogen level, which also in turn leads to a reduction in oxidative stress and inflammatory factors (54). Therefore, regarding low levels of RBP-4 and TNF-α, in the present study, it seems that CRT + ZMSuppl can be effective in reducing inflammatory and injury-causing factors and the prevention and treatment of a variety of chronic inflammatory diseases, such as cardiovascular diseases and diabetes. According to the total presented features of ZM, it can be concluded that perhaps low levels of RBP-4 and TNF-α in the present study were due to the presence of compounds such as glucuronic acid, phenolic compounds and their derivatives, flavonoids, antioxidant features, and other substances available in ZM.

5.1. Conclusions

The findings of the current study showed the positive effect of CRT and ZMSuppl on plasma RBP-4 and TNF-α in postmenopausal females. Therefore, it is likely that regular CRT and consuming traditional herbal medicines such as ZM is a good plan to decrease abnormalities related to insulin, glucose resistance, and inflammatory factors resulting from menopause. The strength of the current study was the type of training that had a kind of impact on adipose tissue and great pressure on heart compared to traditional RT; besides, it determined that ZM combinations with GC-MS, and received food record from participants. But, the weakness was lack of reporting lipid profile and insulin resistance related to RBP-4 changes; due to reports in the other manuscript by other colleagues. The limitations of the current study were lack of control over participants’ motivational condition and access to them when out of training; and also participants’ latent diseases.

References

  • 1.

    Stachowiak G, Pertyński T, Pertyńska-Marczewska M. Metabolic disorders in menopause. Prz Menopauzalny. 2015;14:59-64.

  • 2.

    Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, et al. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab. 2007;92(3):1168-71. [PubMed ID: 17164313]. https://doi.org/10.1210/jc.2006-1839.

  • 3.

    Perseghin G, Lattuada G, De Cobelli F, Esposito A, Belloni E, Canu T, et al. Serum retinol-binding protein-4, leptin, and adiponectin concentrations are related to ectopic fat accumulation. J Clin Endocrinol Metab. 2007;92(12):4883-8. [PubMed ID: 17986645]. https://doi.org/10.1210/jc.2007-0325.

  • 4.

    Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab. 2007;92(7):2712-9. [PubMed ID: 17440021]. https://doi.org/10.1210/jc.2006-1249.

  • 5.

    Qi Q, Yu Z, Ye X, Zhao F, Huang P, Hu FB, et al. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab. 2007;92(12):4827-34. [PubMed ID: 17878249]. https://doi.org/10.1210/jc.2007-1219.

  • 6.

    Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Schleicher E, et al. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care. 2007;30(5):1173-8. [PubMed ID: 17259477]. https://doi.org/10.2337/dc06-2342.

  • 7.

    Huang C, Niu K, Momma H, Kobayashi Y, Guan L, Nagatomi R. Inverse association between circulating adiponectin levels and skeletal muscle strength in Japanese men and women. Nutr Metab Cardiovasc Dis. 2014;24(1):42-9. [PubMed ID: 23786825]. https://doi.org/10.1016/j.numecd.2013.03.006.

  • 8.

    Peterson CA, Heffernan ME. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. J Inflamm (Lond). 2008;5:10. [PubMed ID: 18652680]. https://doi.org/10.1186/1476-9255-5-10.

  • 9.

    Olszanecka-Glinianowicz M, Chudek J, Kocelak P, Szromek A, Zahorska-Markiewicz B. Body fat changes and activity of tumor necrosis factor alpha system--a 5-year follow-up study. Metabolism. 2011;60(4):531-6. [PubMed ID: 20580040]. https://doi.org/10.1016/j.metabol.2010.04.023.

  • 10.

    Zuo H, Shi Z, Hu X, Wu M, Guo Z, Hussain A. Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism. 2009;58(8):1102-8. [PubMed ID: 19481771]. https://doi.org/10.1016/j.metabol.2009.04.008.

  • 11.

    Stefanska A, Sypniewska G, Ponikowska I, Cwiklinska-Jurkowska M. Association of follicle-stimulating hormone and sex hormone binding globulin with the metabolic syndrome in postmenopausal women. Clin Biochem. 2012;45(9):703-6. [PubMed ID: 22449337]. https://doi.org/10.1016/j.clinbiochem.2012.03.011.

  • 12.

    Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 2002;23(1):90-119. [PubMed ID: 11844745]. https://doi.org/10.1210/edrv.23.1.0456.

  • 13.

    Lujan HL, DiCarlo SE. Physical activity, by enhancing parasympathetic tone and activating the cholinergic anti-inflammatory pathway, is a therapeutic strategy to restrain chronic inflammation and prevent many chronic diseases. Med Hypotheses. 2013;80(5):548-52. [PubMed ID: 23395411]. https://doi.org/10.1016/j.mehy.2013.01.014.

  • 14.

    Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 2010;33(12):2692-6. [PubMed ID: 21115771]. https://doi.org/10.2337/dc10-1548.

  • 15.

    Vaisbuch E, Mazaki-Tovi S, Kusanovic JP, Erez O, Than NG, Kim SK, et al. Retinol binding protein 4: an adipokine associated with intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med. 2010;23(2):111-9. [PubMed ID: 19900011]. https://doi.org/10.3109/14767050902994739.

  • 16.

    Saremi A, Gheraati MR. The effect of resistance training on serum myostatin level and insulin resistance in obese-overweight men. Sport Biosci. 2010;108:93-108.

  • 17.

    Pollock ML, Franklin BA, Balady GJ, Chaitman BL, Fleg JL, Fletcher B, et al. AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endorsed by the American College of Sports Medicine. Circulation. 2000;101(7):828-33. [PubMed ID: 10683360].

  • 18.

    Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA, et al. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc. 2004;36(3):533-53. [PubMed ID: 15076798].

  • 19.

    Ogawa K, Sanada K, Machida S, Okutsu M, Suzuki K. Resistance exercise training-induced muscle hypertrophy was associated with reduction of inflammatory markers in elderly women. Mediators Inflamm. 2010;2010:171023. [PubMed ID: 21253481]. https://doi.org/10.1155/2010/171023.

  • 20.

    Karaarslan S, Buyukyazi G, Taneli F, Ulman C, Tikiz C, Gumuşer G, et al. Effects of different intensity resistance exercise programs on bone turnover markers, osteoprotegerin and receptor activator of nuclear factor kappa β ligand in post-menopausal women. Turkiye Klinikleri J Med Sci. 2010;30(1):123-34.

  • 21.

    Alcaraz PE, Sanchez-Lorente J, Blazevich AJ. Physical performance and cardiovascular responses to an acute bout of heavy resistance circuit training versus traditional strength training. J Strength Cond Res. 2008;22(3):667-71. [PubMed ID: 18438256]. https://doi.org/10.1519/JSC.0b013e31816a588f.

  • 22.

    Imayama I, Alfano CM, Kong A, Foster-Schubert KE, Bain CE, Xiao L, et al. Dietary weight loss and exercise interventions effects on quality of life in overweight/obese postmenopausal women: a randomized controlled trial. Int J Behav Nutr Phys Act. 2011;8:118. [PubMed ID: 22026966]. https://doi.org/10.1186/1479-5868-8-118.

  • 23.

    Mohammadi A, Gholamhoseinian A, Fallah H. Zataria multiflora increases insulin sensitivity and PPARgamma gene expression in high fructose fed insulin resistant rats. Iran J Basic Med Sci. 2014;17(4):263-70. [PubMed ID: 24904719].

  • 24.

    Anvari M, Dashti MH, Zeinali F, Hosseini-Bioki SM. The Effect of Thyme (Zataria multiflora Boiss.) Decoction on Pregnancy in Rats. J Med Plants. 2011;2(38):19-25.

  • 25.

    Sodouri M, Masoudi Alavi N, Fathizadeh N, Taghizadeh M, Azarbad Z, Memarzadeh M. Effects of Zataria Multi-Flora, Shirazi thyme, on the Severity of Premenstrual Syndrome. Nurs Midwifery Stud. 2013;2(4):57-63. [PubMed ID: 25414880].

  • 26.

    Iravani M. Clinical effects of Zataria multiflora essential oil on primary dysmenorrhea. J Med Plants. 2009;2(30):54-60.

  • 27.

    Bukovska A, Cikos S, Juhas S, Il'kova G, Rehak P, Koppel J. Effects of a combination of thyme and oregano essential oils on TNBS-induced colitis in mice. Mediators Inflamm. 2007;2007:23296. [PubMed ID: 18288268]. https://doi.org/10.1155/2007/23296.

  • 28.

    Ocana A, Reglero G. Effects of Thyme Extract Oils (from Thymus vulgaris, Thymus zygis, and Thymus hyemalis) on Cytokine Production and Gene Expression of oxLDL-Stimulated THP-1-Macrophages. J Obes. 2012;2012:104706. [PubMed ID: 22577523]. https://doi.org/10.1155/2012/104706.

  • 29.

    Saei-Dehkordi SS, Tajik H, Moradi M, Khalighi-Sigaroodi F. Chemical composition of essential oils in Zataria multiflora Boiss. from different parts of Iran and their radical scavenging and antimicrobial activity. Food Chem Toxicol. 2010;48(6):1562-7. [PubMed ID: 20332011]. https://doi.org/10.1016/j.fct.2010.03.025.

  • 30.

    Ghanbari–Niaki A, Saeidi A, Aliakbari-Beydokhti M, Ardeshiri S, Kolahdouzi S, Chaichi MJ, et al. Effects of Circuit Resistance Training with Crocus Sativus (Saffron) Supplementation on Plasma Viscosity and Fibrinogen. Ann Appl Sport Sci. 2015;3(2):1-10.

  • 31.

    Food Standard Agency. McCance and Widdowson's the composition of foods. Royal Society of Chemistry; 2014.

  • 32.

    Souri RHS, Vahabi K, Shabkhiz F. Effects of interval aerobic training on serum RBP4 and insulin resistance in type 2 diabetic patients. Iran J Diabetes Metabol. 2011;10(4):388-97.

  • 33.

    Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006;354(24):2552-63. [PubMed ID: 16775236]. https://doi.org/10.1056/NEJMoa054862.

  • 34.

    Choi KM, Kim TN, Yoo HJ, Lee KW, Cho GJ, Hwang TG, et al. Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women. Clin Endocrinol (Oxf). 2009;70(4):569-74. [PubMed ID: 18710473]. https://doi.org/10.1111/j.1365-2265.2008.03374.x.

  • 35.

    Lewis JG, Shand BI, Elder PA, Scott RS. Plasma retinol-binding protein is unlikely to be a useful marker of insulin resistance. Diabetes Res Clin Pract. 2008;80(1):e13-5. [PubMed ID: 18194820]. https://doi.org/10.1016/j.diabres.2007.12.002.

  • 36.

    Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, et al. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care. 2006;29(11):2457-61. [PubMed ID: 17065684]. https://doi.org/10.2337/dc06-0360.

  • 37.

    Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest. 1996;97(4):1111-6. [PubMed ID: 8613535]. https://doi.org/10.1172/JCI118504.

  • 38.

    Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes. 1994;43(11):1271-8. [PubMed ID: 7926300].

  • 39.

    Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol. 2005;45(10):1563-9. [PubMed ID: 15893167]. https://doi.org/10.1016/j.jacc.2004.12.077.

  • 40.

    de Salles BF, Simao R, Fleck SJ, Dias I, Kraemer-Aguiar LG, Bouskela E. Effects of resistance training on cytokines. Int J Sports Med. 2010;31(7):441-50. [PubMed ID: 20432196]. https://doi.org/10.1055/s-0030-1251994.

  • 41.

    Fiers W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett. 1991;285(2):199-212. [PubMed ID: 1649771].

  • 42.

    Keller C, Keller P, Giralt M, Hidalgo J, Pedersen BK. Exercise normalises overexpression of TNF-alpha in knockout mice. Biochem Biophys Res Commun. 2004;321(1):179-82. [PubMed ID: 15358232]. https://doi.org/10.1016/j.bbrc.2004.06.129.

  • 43.

    van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest. 1996;97(3):713-9. [PubMed ID: 8609227]. https://doi.org/10.1172/JCI118469.

  • 44.

    Balducci S, Zanuso S, Nicolucci A, Fernando F, Cavallo S, Cardelli P, et al. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis. 2010;20(8):608-17. [PubMed ID: 19695853]. https://doi.org/10.1016/j.numecd.2009.04.015.

  • 45.

    Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. Arch Intern Med. 2008;168(14):1568-75. [PubMed ID: 18663170]. https://doi.org/10.1001/archinte.168.14.1568.

  • 46.

    Okazaki K, Kawazoe K, Takaishi Y. Human platelet aggregation inhibitors from thyme (Thymus vulgaris L.). Phytother Res. 2002;16(4):398-9. [PubMed ID: 12112303]. https://doi.org/10.1002/ptr.979.

  • 47.

    Lixandru BE, Dracea NO, Dragomirescu CC, Dragulescu EC, Coldea IL, Anton L, et al. Antimicrobial activity of plant essential oils against bacterial and fungal species involved in food poisoning and/or food decay. Roum Arch Microbiol Immunol. 2010;69(4):224-30. [PubMed ID: 21462837].

  • 48.

    Lee KG, Shibamoto T. Determination of antioxidant potential of volatile extracts isolated from various herbs and spices. J Agric Food Chem. 2002;50(17):4947-52. [PubMed ID: 12166987].

  • 49.

    Dorman HJD, Peltoketo A, Hiltunen R, Tikkanen MJ. Characterisation of the antioxidant properties of de-odourised aqueous extracts from selected Lamiaceae herbs. Food Chem. 2003;83(2):255-62.

  • 50.

    Lee SJ, Umano K, Shibamoto T, Lee KG. Identification of volatile components in basil (Ocimum basilicum L.) and thyme leaves (Thymus vulgaris L.) and their antioxidant properties. Food Chem. 2005;91(1):131-7.

  • 51.

    Sabu AMC, Kuttan R. Medicinal plants and its relation Antidiabetic activity of ship with their antioxidant property. J Ethnopharmacol. 1999;2:155-60.

  • 52.

    Rana P, Soni G. Antioxidant potential of thyme extract: alleviation of N-nitrosodiethylamine-induced oxidative stress. Hum Exp Toxicol. 2008;27(3):215-21. [PubMed ID: 18650253]. https://doi.org/10.1177/0960327108088970.

  • 53.

    Kim HJ, Chung JI, Lee SH, Jung YS, Moon CH, Baik EJ. Involvement of endogenous prostaglandin F2alpha on kainic acid-induced seizure activity through FP receptor: the mechanism of proconvulsant effects of COX-2 inhibitors. Brain Res. 2008;1193:153-61. [PubMed ID: 18178179]. https://doi.org/10.1016/j.brainres.2007.12.017.

  • 54.

    Diaz-Cruz ES, Shapiro CL, Brueggemeier RW. Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. J Clin Endocrinol Metab. 2005;90(5):2563-70. [PubMed ID: 15687328]. https://doi.org/10.1210/jc.2004-2029.